Study of the Safety, Tolerability and Immunogenicity of an Intranasal Influenza Vaccine Administered to Healthy Adults
Clinical trial NCT03293732 · COMPLETED
Trial details
- NCT number
- NCT03293732
- Sponsor
- Advagene Biopharma Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-28
- Primary completion
- 2013-03-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.